Is Nemaura Medical Inc. (NMRD) a Buy, Sell, or Hold?
Nemaura Medical Inc.
NASDAQ:NMRD
$0.0002 USD
$0.0 (100.0%)
- Volume
- 325
- Average Volume
- 8.54K
- Market Capitalization
- $8.07K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $0.26
- Year Low
- $0.00
- Payout Ratio
- $0.00
- Current Ratio
- $0.19
Industry, Sector & symbol
| Stock Exchange | NASDAQ Capital Market |
| CEO | Dr. Dewan Fazlul Hoque Chowdhury Ph.D. |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Current Symbol | NMRD |
| CUSIP | 640442208 |
| CIK | 0001602078 |
| Web | https://nemauramedical.com |
| Phone | 646 416 7912 |
| Currency | USD |
| Employees | 36 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | -1.10 |
| Payout Ratio | 0.00 |
| Current Ratio | 0.19 |
| Quick Ratio | 0.03 |
| Cash Ratio | 0.01 |
Sales & Book Value
| Annual Sales | $77044 |
| Price / Sales | 0.00 |
| Cash Flow | -0.25 |
| Price / Cash Flow | 0.00 |
| Price / Book | 0.00 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 2 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.57 |
| Trailing P/E Ratio | 0.00 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | $-14.14M |
| Net Margin | 0.00% |
| Pretax Margin | 0.00% |
| Return on Equity | 37.24% |
| Return on Assets | -115.46% |
Financials Score
| AltmanZ Score | -25.18 |
| Piotroski Score | 1.00 |
| Working Capital | -18.62M |
| Total Assets | 5.17M |
| Ebit | -7.66M |
| Market Cap | 8.07K |
| Total Liabilities | 23M |
Poll Results
About Nemaura Medical Inc. (NASDAQ:NMRD) Stock
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York. ...
Important Update on Listing Status and Strategic Direction
2024-01-03 07:00:00
Loughborough, UK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs, is providing a crucial update regarding recent decisions that will impact Nemaura Medical's listing status on The Nasdaq Capital Market and our broader strategic direction.
Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision
2023-12-13 08:00:00
Loughborough, UK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce that the Nasdaq Hearings Panel granted the Company's request for continued listing pursuant to an exception, including certain interim milestones, that ultimately expires on April 1st, 2024, to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market.
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
2023-11-21 08:30:00
Loughborough, UK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce the execution of a strategic agreement for a $10 million credit facility which is expected to support the Company's strategic growth plans.
Nemaura (NMRD) to Expand in UK With Metabolic Health Program
2023-11-17 12:47:09
The latest program leverages Nemaura's (NMRD) world-first daily wear non-invasive CGM technology, providing individuals with real-time insights into their body's glucose dynamics.
2023-11-14 08:00:00
Company CEO to discuss development at 1pm EST on 15 th November 2023, at the Sidoti Virtual Investor Conference
Frequently Asked Questions
-
What is the current Nemaura Medical Inc. (NMRD) stock price?
-
Nemaura Medical Inc.(NASDAQ:NMRD) stock price is $0.0002 in the last trading session. During the trading session, NMRD stock reached the peak price of $4 while $1.0E was the lowest point it dropped to. The percentage change in NMRD stock occurred in the recent session was 100.0% while the dollar amount for the price change in NMRD stock was $0.0.
-
NMRD's industry and sector of operation?
-
The NASDAQ listed NMRD is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of NMRD?
-
Dr. Dewan Fazlul Hoque Chowdhury Ph.D. | Chairman, Interim Chief Financial Officer, Chief Executive Officer, President and Principal Financial & Accounting Officer
Mr. Jay L. Warner | Head of U.S. Commercial Operations
Mr. Thomas Bendix Mortensen | Head of E.U. Commercial Operations & Marketing
Ms. Samantha Sanders | Global Head of Digital Programs
| -
How many employees does NMRD have?
-
Number of NMRD employees currently stands at 36. NMRD operates from 57 West 57th Street, New York, NY 10019, US.
-
Link for NMRD official website?
-
Official Website of NMRD is: https://nemauramedical.com
-
How do I contact NMRD?
-
NMRD could be contacted at phone #646 416 7912 and can also be accessed through its website. NMRD operates from 57 West 57th Street, New York, NY 10019, US.
-
How many shares of NMRD are traded daily?
-
The average number of NMRD shares traded daily for last 3 months was 8.54K.
-
What is the market cap of NMRD currently?
-
The market value of NMRD currently stands at $8.07K with its latest stock price at $0.0002